Alpa Laboratories

Alpa Laboratories EBIT Margin

The EBIT Margin (Operating Margin) of Alpa Laboratories (ALPA.NS) as of Oct 17, 2026 is 2.31 %. In the previous year, EBIT Margin (Operating Margin) was 5.66 % — a change of -59.11% (lower).

EBIT Margin

2.31 %

YoY

-59.11%

Last updated:

EBIT Margin (Operating Margin) of Alpa Laboratories is 2025 2.31 % . EBIT Margin (Operating Margin) of Alpa Laboratories was 2024 5.66 % . It decreases by -59.11% lower compared to the previous year.

For Alpa Laboratories, the operating (EBIT) margin of 2.3% is down versus 6.6% a few years ago.

The Alpa Laboratories EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
1.36 INR
Jan 1, 2019
-2.53 INR
Jan 1, 2020
0.22 INR
Jan 1, 2021
6.63 INR
Jan 1, 2022
8.02 INR
Jan 1, 2023
7.26 INR
Jan 1, 2024
5.66 INR
Jan 1, 2025
2.31 INR
The Alpa Laboratories EBIT Margin history
YEAREBIT MarginYoY
2.31 %-59.11%
5.66 %-22.05%
7.26 %-9.52%
8.02 %+20.97%
6.63 %+2,879.60%
0.22 %-108.79%
-2.53 %-286.45%
1.36 %-61.03%
3.48 %-68.89%
11.20 %-342.55%
-4.62 %-21.14%
-5.85 %+18,774.60%
-0.03 %-208.89%
0.03 %+274.60%
0.01 %-35.44%
0.01 %+37.83%
0.01 %-85.81%
0.06 %-13.96%
0.07 %-31.90%
0.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Alpa Laboratories Stock analysis

What does Alpa Laboratories do? Alpa Laboratories Ltd is a pharmaceutical company headquartered in Indore, India, with 318 employees. It operates in the Health Care sector within the Pharmaceuticals industry. The company went public on August 1, 2007. Its product range includes generic and over-the-counter drugs for human and veterinary use, such as capsules, creams, gels, ointments, ear and eye drops, and tablets. Human products feature Ampicillin Capsule, Amoxycillin Trihydrate Capsule, and Paracetamol Tablet, while veterinary products include Alpamin Bolus and Atropine Inj. B.Vet.C. Alpa Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alpa Laboratories stock

EBIT Margin (Operating Margin) of Alpa Laboratories is 2.31 % in 2025.

EBIT Margin (Operating Margin) of Alpa Laboratories changed from 5.66 % to 2.31 %, representing a -59.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Alpa Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Alpa Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Alpa Laboratories

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Alpa Laboratories